查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466746

细胞培养市场：按产品、应用和最终用途 - 2024-2030 年全球预测

Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年细胞培养市场规模为262.9亿美元，预计2024年将达301.2亿美元，2030年将达682亿美元，复合年增长率为14.58%。

细胞培养是一种实验技术，用于在不同于自然环境（例如活生物体）的受控环境中培养细胞。这种方法使研究人员和科学家能够详细研究细胞行为、生物学和生理学。细胞培养应用于医学研究、製药、生物技术等各个领域，甚至製造业的某些部分。细胞培养技术的应用范围广泛，包括药物开发、疫苗生产、癌症研究、基因工程和生技药品的生产。它在新药开发、毒性测试、疾病机制阐明等方面发挥重要作用。在製药和生物技术产业，细胞培养在生物製药和抗体的生产中发挥着至关重要的作用。此外，细胞培养在再生医学和组织工程中的作用凸显了其在製定慢性疾病和病理治疗策略中的重要性。细胞培养市场的成长是由3D细胞培养和自动化细胞培养系统等细胞培养技术的创新、对治疗性单株抗体的需求增加、对生物技术和药物研究活动的投资增加以及全球慢性病需求的增加所推动的。然而，细胞培养市场面临某些限制，例如高成本、伦理问题、培养维护的复杂性以及与先进细胞培养技术相关的污染风险。同时，3D细胞培养技术的进步、细胞培养在个人化医疗中的应用以根据个体的基因谱定制治疗方案、细胞培养在再生医学中的应用研究以及细胞培养在永续食品生产中的应用正在快速成长。

主要市场统计
基准年[2023] 262.9亿美元
预测年份 [2024] 301.2亿美元
预测年份 [2030] 682亿美元
复合年增长率（%） 14.58%

产品：细胞培养将越来越青睐具有可靠性、可扩展性和先进功能的设备。

消耗品是指经常使用并需要更换的产品。它在确保细胞培养操作的品质和完整性方面发挥着重要作用。反应器配件是反应器中使用的组件，支援生物活性环境的设备，以提高其效率和产量。培养基是细胞生长的营养丰富的溶液，分为经典培养基和无盐无血清培养基。试剂是添加到细胞培养物中以产生所需效果的物质或化合物，例如用于防止细菌/真菌污染或防止细胞黏附到培养容器的抗生素/抗真菌剂，其中包括辅助的黏附/基质因子。细胞工厂系统/细胞堆、烧瓶和多孔孔盘是培养细胞的容器。它们有各种尺寸和型态，并经过定制以满足不同类型细胞培养的需求。传统或一次性反应器对于研究和生产目的的大量培养细胞反应器。特别是，一次性反应器因其便利性和降低污染风险而受到关注。低温保存系统、冰箱和冷冻库对于将细胞和生物样本保存在适当的温度以确保长期活力至关重要。高压釜、生物安全柜和二氧化碳培养箱对于维持无菌环境和确保细胞培养的安全性和完整性至关重要。耗材是一项持续支出，长远来看会对细胞培养的整体营运成本产生重大影响。另一方面，设备需要较高的初始投资，但使用寿命较长，长期来看可能会降低成本。虽然耗材选择通常侧重于品质、批次一致性和道德考虑，但设备偏好倾向于可靠性、可扩展性和增强培养条件和监控的高级功能。

最终用途：透过扩大细胞培养在医院和诊断实验室的使用来提高效率和诊断准确性

在医院和诊断实验室中，细胞培养主要用于诊断目的，例如癌症诊断、病毒检测和药物筛检。随着对准确性、可靠性和速度的关注，人们对自动化细胞培养系统越来越感兴趣，以简化工作流程并减少人为错误。製药和生物技术公司在考虑细胞培养在药物开发、生技药品製造和疫苗製造中的应用时，优先考虑可扩展性、一致性和法规遵循。重点是高产、经济高效的培养系统，可以缩短新疗法的上市时间。研究和学术机构正在转向弹性、多样化和特定的细胞培养产品来支持广泛的研究领域，包括干细胞研究、癌症研究和再生医学。这里的需求是专业的培养基配方、先进的培养系统（如 3D 培养）以及对尖端研究活动的支援。比较这三个细分市场表明，每个细分市场都有由其最终目标决定的自己的需求。医院和诊断实验室优先考虑效率和诊断准确性，製药和生物技术公司优先考虑治疗製造的可扩展性和合规性，研究机构和学术机构寻求广泛的研究应用的多功能性。

区域洞察

美国作为生物技术研发中心，是细胞培养产品的重要市场。该地区的需求是由强大的研究基础设施、对生命科学的大量投资以及大型製药和生物技术公司的存在所推动的。对个人化医疗和再生疗法的关注将进一步提振市场。由于公共和私营部门不断增加的研发投资，南美细胞培养市场正处于成长阶段。由于生物製药行业的扩张、生命科学投资的增加以及政府对生物技术新兴企业的支持，亚太地区对细胞培养的需求正在激增。在政府旨在促进再生医学、生技药品製造和干细胞研究的倡议的支持下，中国市场正在蓬勃发展。日本先进的医疗系统和对品质的重视使其成为先进细胞培养系统的重要市场。印度细胞培养市场在蓬勃发展的生物技术产业、不断增加的生物医学研究以及疫苗和生技药品生产的推动下不断增长。欧盟因其强大的研究能力、法律规范以及在生物技术和製药领域的大量投资而脱颖而出。癌症研究、再生医学和疫苗製造等活跃的研究领域正在推动对细胞培养产品的需求。成员国之间的合作研究措施进一步加强了市场。儘管中东和非洲地区是一个新兴地区，但由于医疗投资的增加以及生命科学领域研发活动的逐渐转向，细胞培养显示出成长潜力。

FPNV定位矩阵

FPNV定位矩阵对于评估细胞培养市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对细胞培养市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析也为此细分市场的竞争特征提供了宝贵的见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动以及突破性产品开发的见解。

本报告解决了以下关键问题：

1.细胞培养市场的市场规模与预测是多少？

2.在细胞培养市场预测期内需要考虑投资的产品、细分市场、应用和细分市场有哪些？

3. 细胞培养市场的技术趋势和法规结构是什么？

4.细胞培养市场主要厂商的市场占有率为何？

5.进入细胞培养市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对治疗用途单株抗体的需求增加
      • 增加对生物技术和药物研究活动的投资
      • 世界各地慢性病的发生率正在上升
    • 抑制因素
      • 与先进的细胞培养技术和无菌条件的维持相关的高成本
    • 机会
      • 扩大细胞培养在个人化医疗的应用，根据个人的遗传特征客製化治疗方案
      • 利用细胞培养实现永续食品生产的培养肉需求不断增长
    • 任务
      • 培养物维护的复杂性与污染风险
  • 市场区隔分析
    • 产品：可靠、可扩展且功能强大的细胞培养设备正在成为优先考虑的因素
    • 最终用途：扩大细胞培养在医院和诊断实验室的使用，以提高效率和诊断准确性
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章细胞培养市场：副产品

  • 介绍
  • 消耗品
  • 装置

第七章细胞培养市场：依应用分类

  • 介绍
  • 生物製药製造
  • 诊断
  • 药物筛检与开发
  • 干细胞研究
  • 组织工程与再生医学

第八章细胞培养市场：依最终用途

  • 介绍
  • 医院和诊断实验室
  • 製药和生物技术公司
  • 研究/学术机构

第九章美洲细胞培养市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太细胞培养市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲细胞培养市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-034230D3E63B

[186 Pages Report] The Cell Culture Market size was estimated at USD 26.29 billion in 2023 and expected to reach USD 30.12 billion in 2024, at a CAGR 14.58% to reach USD 68.20 billion by 2030.

Cell culture is a laboratory method used to grow cells in a controlled environment outside of their natural setting, such as a living organism. This method allows researchers and scientists to study the behavior, biology, and physiology of cells in detail. Cell culture is utilized in various fields, including medical research, pharmaceuticals, biotechnology, and even some aspects of manufacturing. The applications of cell culture technology are vast and varied, encompassing drug development, vaccine production, cancer research, genetic engineering, and the manufacture of biologics, among others. It plays a crucial role in developing new medicines, testing for toxicity, and understanding disease mechanisms. In the pharmaceutical and biotechnology industries, cell culture is pivotal in producing biopharmaceuticals and antibodies. Moreover, its role in regenerative medicine and tissue engineering underlines its significance in developing therapeutic strategies for chronic diseases and conditions. Several factors contribute positively to the growth of the cell culture market, including innovations in cell culture technologies, such as 3D cell culture and automated cell culture systems, growing demand for monoclonal antibodies for therapeutic applications, higher investment in biotechnology and pharmaceutical research activities, and rising incidence of chronic diseases worldwide. However, the cell culture market faces certain limitations, such as the high costs associated with advanced cell culture technologies, ethical issues, the complexity of maintaining cultures, and the risk of contamination. On the other hand, advancements in 3D cell culture technology, the use of cell culture in personalized medicine for tailoring treatments to individual genetic profiles, research into cell culture applications in regenerative medicine, and the burgeoning field of cultured meat, using cell culture for sustainable food production opens new avenues for the development of cell culture market.

KEY MARKET STATISTICS
Base Year [2023] USD 26.29 billion
Estimated Year [2024] USD 30.12 billion
Forecast Year [2030] USD 68.20 billion
CAGR (%) 14.58%

Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features

Consumables are products that are regularly used up and need replacement. They play a critical role in ensuring the quality and integrity of cell culture work. Bioreactor accessories are components used with bioreactors, devices that support a biologically active environment, to improve their efficiency and output. Media is the nutrient-rich solution that cells grow in, and It can be divided into classical media & salts and serum-free media. Reagents are substances or compounds added to the cell culture to bring about a desired effect, such as antibiotics/antimycotics used to prevent bacterial/fungal contamination; attachment & matrix factors to help cells attach to the culture vessel; and balanced salt solutions to maintain the osmotic balance and pH. Cell factory systems/cell stacks, flasks, and multiwell plates are containers where cells are grown. They come in various sizes and shapes, tailored to different types of cell culture needs. Conventional bioreactors and single-use bioreactor devices are essential for growing cells in large quantities for research or production purposes. Single-use bioreactors are particularly noted for their convenience and reduced contamination risk. Cryostorage systems, refrigerators & freezers are vital for preserving cells and biological materials at appropriate temperatures, ensuring they remain viable over time. Autoclaves, biosafety cabinets, and carbon dioxide incubators are essential to maintain a sterile environment, ensuring the safety and integrity of cell cultures. Consumables are a continuous expense and can significantly impact the overall cost of cell culture operations in the long term. In contrast, equipment represents a higher initial investment but offers a longer service life, potentially reducing costs over time. Selection of consumables often focuses on quality, batch consistency, and ethical considerations, whereas equipment preferences lean towards reliability, scalability, and advanced features that enhance culture conditions and monitoring.

End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy

In hospitals and diagnostic laboratories, cell culture is primarily employed for diagnostic purposes, including cancer diagnosis, virology studies, and drug screening. The emphasis is on accuracy, reliability, and speed, with a growing interest in automated cell culture systems to streamline workflow and reduce human error. Pharmaceutical & biotechnology companies prioritize scalability, consistency, and regulatory compliance, given the cell culture applications in drug development, biologics production, and vaccine manufacturing. The focus is on high-yield, cost-effective culture systems that can expedite the time-to-market for new therapeutics. Research and academic institutes focus on flexibility, variety, and specificity in cell culture products to support a broad range of research areas, including stem cell research, cancer research, and regenerative medicine. The demand here is for specialized media formulations, advanced culture systems such as 3D cultures, and support for cutting-edge research endeavors. Upon comparing the three segments, it becomes evident that each has unique requirements shaped by their end goals. Hospitals and diagnostic laboratories prioritize efficiency and diagnostic accuracy, pharmaceutical and biotechnology companies focus on scalability and compliance for therapeutic production, and research and academic institutes demand versatility for a wide swath of research applications.

Regional Insights

The United States, being a hub for biotechnological research and development, stands out as a significant market for cell culture products. The demand here is driven by a robust research infrastructure, substantial investments in life sciences, and the existence of major pharmaceutical and biotechnology companies. The focus on personalized medicine and regenerative therapies further boosts the market. The South American cell culture market is in a growth phase, fueled by increasing investment in research and development by both public and private sectors. The Asia Pacific region is experiencing rapid growth in cell culture demand due to its expanding biopharmaceutical sector, increasing investments in life sciences, and government support for biotechnology startups. China's market is booming, supported by government initiatives aimed at advancing regenerative medicine, biologics production, and stem cell research. Japan's sophisticated healthcare system and strong emphasis on quality are significant markets for advanced cell culture systems. India's cell culture market is growing, fueled by its burgeoning biotech industry, increased biomedical research, and the production of vaccines and biologics. The EU stands out for its strong research capabilities, regulatory frameworks, and substantial investments in the biotechnology and pharmaceutical sectors. The demand for cell culture products is driven by active research areas, including cancer research, regenerative medicine, and vaccine production. Collaborative research initiatives across member states further enhance the market. The Middle East and Africa region, although emerging, shows potential for growth in cell culture due to increasing healthcare investment and a gradual shift towards research and developmental activities in the life sciences sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Market, highlighting leading vendors and their innovative profiles. These include Adolf Kuhner AG, Advancion Corporation, Agilent Technologies, Inc., Becton, Dickinson, and Company, Bio-Techne Corporation, BioSpherix Ltd., Caisson Labs Inc., CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Getinge AB, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PAN-Biotech GmbH, PromoCell GmbH, Sartorius AG, Solida Biotech GmBH, STEMCELL Technologies Canada Inc., Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
      • Bioreactor Accessories
      • Sera, Media, and Reagents
        • Media Classical Media & Salts

Serum-Free Media

Specialty Media

Stem Cell Culture Media

        • Reagents Antibiotics/Antimycotics

Attachment & Matrix Factors

Balanced Salt Solutions

Buffers & Chemicals

Cell Dissociation Reagents

Contamination Detection Kits

Cryoprotective Reagents

        • Sera Adult Bovine Sera

Fetal Bovine Sera

      • Vessels
        • Cell Factory Systems/Cell Stacks
        • Flasks
        • Multiwell Plates
        • Petri Dishes
        • Roller/Roux Bottles
    • Equipment
      • Bioreactors
        • Conventional Bioreactors
        • Single-Use Bioreactors
      • Storage Equipment
        • Cryostorage System
        • Refrigerators & Freezers
      • Supporting Equipment
        • Autoclaves
        • Biosafety Cabinets
        • Carbon Dioxide Incubators
        • Cell Counters
        • Centrifuges
        • Filtration System
        • Microscopes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibody Production
      • Vaccine Production
    • Diagnostics
    • Drug Screening & Development
    • Stem Cell Research
    • Tissue Engineering & Regenerative Medicine
  • End-Use
    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Culture Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Culture Market?

3. What are the technology trends and regulatory frameworks in the Cell Culture Market?

4. What is the market share of the leading vendors in the Cell Culture Market?

5. Which modes and strategic moves are suitable for entering the Cell Culture Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for monoclonal antibodies for therapeutic applications
      • 5.1.1.2. Increased investment in biotechnology and pharmaceutical research activities
      • 5.1.1.3. Rising incidence of chronic diseases worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced cell culture technologies and the maintenance of sterile conditions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding the use of cell culture in personalized medicine for tailored treatments to individual genetic profiles
      • 5.1.3.2. Burgeoning demand for cultured meat, using cell culture for sustainable food production
    • 5.1.4. Challenges
      • 5.1.4.1. The complexity of maintaining cultures and the risk of contamination
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for equipments in cell culture for reliability, scalability, and advanced features
    • 5.2.2. End-Use: Expanding usage of cell culture in hospitals and diagnostic laboratories for efficiency and diagnostic accuracy
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment

7. Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceutical Production
  • 7.3. Diagnostics
  • 7.4. Drug Screening & Development
  • 7.5. Stem Cell Research
  • 7.6. Tissue Engineering & Regenerative Medicine

8. Cell Culture Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals & Diagnostic Laboratories
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. Americas Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Embarks on a USD 500 Million Expansion Project in Austrian Biopharmaceutical Manufacturing
    • 12.3.2. Molecular Devices Unveils the CellXpress AI Automated Cell Culture System
    • 12.3.3. Strategic Alliance Elevates Stem Cell Research Accessibility and Efficiency
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL CULTURE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTOR ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MARKET SIZE, BY CLASSICAL MEDIA & SALTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MARKET SIZE, BY ATTACHMENT & MATRIX FACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY BALANCED SALT SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY BUFFERS & CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MARKET SIZE, BY CONTAMINATION DETECTION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOPROTECTIVE REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MARKET SIZE, BY ADULT BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MARKET SIZE, BY FETAL BOVINE SERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CELL CULTURE MARKET SIZE, BY CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CELL CULTURE MARKET SIZE, BY FLASKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CELL CULTURE MARKET SIZE, BY MULTIWELL PLATES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CELL CULTURE MARKET SIZE, BY PETRI DISHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CELL CULTURE MARKET SIZE, BY ROLLER/ROUX BOTTLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CELL CULTURE MARKET SIZE, BY CONVENTIONAL BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL CELL CULTURE MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL CELL CULTURE MARKET SIZE, BY CRYOSTORAGE SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL CELL CULTURE MARKET SIZE, BY REFRIGERATORS & FREEZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL CELL CULTURE MARKET SIZE, BY AUTOCLAVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL CELL CULTURE MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL CELL CULTURE MARKET SIZE, BY CARBON DIOXIDE INCUBATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY CELL COUNTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL CELL CULTURE MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 106. GLOBAL CELL CULTURE MARKET SIZE, BY FILTRATION SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 107. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 108. GLOBAL CELL CULTURE MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 109. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 112. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 113. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 114. GLOBAL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 115. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 116. GLOBAL CELL CULTURE MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 117. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 118. GLOBAL CELL CULTURE MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 119. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 120. GLOBAL CELL CULTURE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 121. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 122. GLOBAL CELL CULTURE MARKET SIZE, BY DRUG SCREENING & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 123. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 124. GLOBAL CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 125. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 126. GLOBAL CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 127. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. GLOBAL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 130. GLOBAL CELL CULTURE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 131. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 132. GLOBAL CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 133. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 134. GLOBAL CELL CULTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 135. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. AMERICAS CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 138. AMERICAS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 139. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 140. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 141. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 142. AMERICAS CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 143. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 144. AMERICAS CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 145. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 146. AMERICAS CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 147. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 148. AMERICAS CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 149. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 150. AMERICAS CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 151. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 152. AMERICAS CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 153. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 154. AMERICAS CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 155. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 156. AMERICAS CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 157. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. AMERICAS CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 160. AMERICAS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 161. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. AMERICAS CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. AMERICAS CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. ARGENTINA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 168. ARGENTINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 169. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 170. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 171. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 172. ARGENTINA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 173. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 174. ARGENTINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 175. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 176. ARGENTINA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 177. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 178. ARGENTINA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 179. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 180. ARGENTINA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 181. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 182. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 183. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 184. ARGENTINA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 185. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 186. ARGENTINA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 187. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ARGENTINA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 190. ARGENTINA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 191. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. ARGENTINA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. BRAZIL CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 196. BRAZIL CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 197. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 198. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 199. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 200. BRAZIL CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 201. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 202. BRAZIL CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 203. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 204. BRAZIL CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 205. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 206. BRAZIL CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 207. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 208. BRAZIL CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 209. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 210. BRAZIL CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 211. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. BRAZIL CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 214. BRAZIL CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 215. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. BRAZIL CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 218. BRAZIL CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 219. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 220. BRAZIL CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 221. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. CANADA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 224. CANADA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 225. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 226. CANADA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 227. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 228. CANADA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 229. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 230. CANADA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 231. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 232. CANADA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 233. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 234. CANADA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 235. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 236. CANADA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 237. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 238. CANADA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 239. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 240. CANADA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 241. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 242. CANADA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 243. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. CANADA CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 246. CANADA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 247. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. CANADA CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. MEXICO CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 252. MEXICO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 253. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 254. MEXICO CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 255. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 256. MEXICO CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 257. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 258. MEXICO CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 259. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 260. MEXICO CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 261. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 262. MEXICO CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 263. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 264. MEXICO CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 265. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 266. MEXICO CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 267. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 268. MEXICO CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 269. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 270. MEXICO CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 271. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. MEXICO CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 274. MEXICO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 275. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. MEXICO CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED STATES CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED STATES CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED STATES CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 297. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 298. UNITED STATES CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 299. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 302. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 303. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 304. UNITED STATES CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 305. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 306. UNITED STATES CELL CULTURE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2023 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2024-2030 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 335. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 336. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 337. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. AUSTRALIA CELL CULTURE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 340. AUSTRALIA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 341. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 342. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, MEDIA, AND REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 343. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
  • TABLE 344. AUSTRALIA CELL CULTURE MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
  • TABLE 345. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
  • TABLE 346. AUSTRALIA CELL CULTURE MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
  • TABLE 347. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2018-2023 (USD MILLION)
  • TABLE 348. AUSTRALIA CELL CULTURE MARKET SIZE, BY SERA, 2024-2030 (USD MILLION)
  • TABLE 349. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2018-2023 (USD MILLION)
  • TABLE 350. AUSTRALIA CELL CULTURE MARKET SIZE, BY VESSELS, 2024-2030 (USD MILLION)
  • TABLE 351. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 352. AUSTRALIA CELL CULTURE MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 353. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
  • TABLE 354. AUSTRALIA CELL CULTURE MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
  • TABLE 355. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 356. AUSTRALIA CELL CULTURE MARKET SIZE, BY STORAGE EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 357. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 358. AUSTRALIA CELL CULTURE MARKET SIZE, BY SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 359. AUSTRALIA CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 360. AUSTRALIA C